Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Mid-range Performer

1014.5000 21.90 (2.21%)

NSE Mar 25, 2026 11:59 AM

95.98% Gain from 52W Low

Volume: 652.8K

Laurus Labs Ltd.

24 Oct 2025, 12:00AM

1014.50

2.21%

Laurus Labs (HOLD): Operating leverage to emerge slower

Hold: Laurus Labs Ltd.

Target

BOB Capital Markets Ltd.

Sales /EBITDA/PAT surpassed our estimates by 18%, 28% and 75%; exceeded consensus by 11%. 31% and 74% respectively

Laurus Labs Ltd. is trading above its 200 day SMA of 924.9